Wirth Edward 4
4 · BIOTIME INC · Filed Mar 21, 2019
Insider Transaction Report
Form 4
BIOTIME INCBTX
Wirth Edward
Chief Medical Officer
Transactions
- Award
Option to Purchase Common Shares
2019-03-19+350,000→ 350,000 totalExercise: $1.57Exp: 2029-03-18→ Common Shares (350,000 underlying)
Footnotes (1)
- [F1]One quarter of the options shall vest on March 18, 2020 and the remaining shall vest in 36 equal monthly installments thereafter upon the completion of each month of continuous employment.